Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
Eur Respir J. 2017 Aug 10;50(2):1700050. doi: 10.1183/13993003.00050-2017. Print 2017 Aug.
Eur Respir J. 2017.
PMID: 28798088
Free article.
Clinical Trial.